Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W V Brown

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
The American Journal of Cardiology|March 21, 2001
Novel approaches to lipid lowering: what is on the horizon?W V Brown
The American Journal of Cardiology|September 4, 1990
Clinical trials including an update on the Helsinki Heart StudyW V Brown
Postgraduate Medicine|August 1, 1995
Niacin for lipid disorders. Indications, effectiveness, and safetyW V Brown
The Medical Clinics of North America|January 1, 1994
Lipoprotein disorders in diabetes mellitusW V Brown
Clinical Cardiology|November 1, 1992
When do we treat hypercholesterolemia?W V Brown
The American Journal of Cardiology|May 26, 1994
Hydroxymethylglutaryl coenzyme a reductase inhibition: fluvastatin, a clinical investigators' update. IntroductionW V Brown
Hospital Practice (Office Ed.)|June 1, 1988
Focus on fenofibrateW V Brown
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1972
Some functional aspects of the plasma apolipoproteinsW V Brown
European Heart Journal|December 1, 1990
Review of clinical trials: proving the lipid hypothesisW V Brown
Circulation|May 1, 1992
President's address to the 64th scientific sessions of the American Heart AssociationW V Brown
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
The American Journal of Cardiology|March 21, 2001
Novel approaches to lipid lowering: what is on the horizon?W V Brown
The American Journal of Cardiology|September 4, 1990
Clinical trials including an update on the Helsinki Heart StudyW V Brown
Postgraduate Medicine|August 1, 1995
Niacin for lipid disorders. Indications, effectiveness, and safetyW V Brown
The Medical Clinics of North America|January 1, 1994
Lipoprotein disorders in diabetes mellitusW V Brown
Clinical Cardiology|November 1, 1992
When do we treat hypercholesterolemia?W V Brown
The American Journal of Cardiology|May 26, 1994
Hydroxymethylglutaryl coenzyme a reductase inhibition: fluvastatin, a clinical investigators' update. IntroductionW V Brown
Hospital Practice (Office Ed.)|June 1, 1988
Focus on fenofibrateW V Brown
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1972
Some functional aspects of the plasma apolipoproteinsW V Brown
European Heart Journal|December 1, 1990
Review of clinical trials: proving the lipid hypothesisW V Brown
Circulation|May 1, 1992
President's address to the 64th scientific sessions of the American Heart AssociationW V Brown
Pageof 15